{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:48:59Z","timestamp":1792194539743,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejpb.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T07:06:55Z","timestamp":1611990415000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery"],"prefix":"10.1016","volume":"160","author":[{"given":"Daniel","family":"Porat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vaynshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Gibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opal","family":"Avramoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Shaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Dukhno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Czeiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Sebbag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.01.016_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134116","article-title":"The evolution of stomach acidity and its relevance to the human microbiome","volume":"10","author":"Beasley","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2021.01.016_b0010","doi-asserted-by":"crossref","unstructured":"L. Angrisani, A. Santonicola, P. Iovino, A. Vitiello, K. Higa, J. Himpens, H. Buchwald, N. Scopinaro, IFSO worldwide survey 2016: Primary, endoluminal, and revisional procedures, Obes. Surg., 28 (2018) 3783-3794.","DOI":"10.1007\/s11695-018-3450-2"},{"key":"10.1016\/j.ejpb.2021.01.016_b0015","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1021\/mp400256h","article-title":"Impaired drug absorption due to high stomach pH: A review of strategies for mitigation of such effect to enable pharmaceutical product development","volume":"10","author":"Mitra","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0020","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/jcm9092827","article-title":"Treatment of COVID-19 patients post-bariatric surgery: Issues for consideration","volume":"9","author":"Azran","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejpb.2021.01.016_b0025","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/obr.12434","article-title":"Oral drug therapy following bariatric surgery: An overview of fundamentals, literature and clinical recommendations","volume":"17","author":"Azran","year":"2016","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ejpb.2021.01.016_b0030","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/17425255.2012.722757","article-title":"The effects of gastric bypass surgery on drug absorption and pharmacokinetics","volume":"8","author":"Brocks","year":"2012","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/obr.12869","article-title":"The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review","volume":"20","author":"Angeles","year":"2019","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ejpb.2021.01.016_b0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.soard.2017.03.003","article-title":"Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass","volume":"13","author":"Azran","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.ejpb.2021.01.016_b0045","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.soard.2016.03.015","article-title":"Methylphenidate toxicity after Roux-en-Y gastric bypass","volume":"12","author":"Ludvigsson","year":"2016","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.ejpb.2021.01.016_b0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.2042-7158.2012.01538.x","article-title":"A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: Interplay between CYP3A gut wall metabolism, permeability and dissolution","volume":"64","author":"Darwich","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02453-19","article-title":"Case report of increased exposure to antiretrovirals following sleeve gastrectomy","volume":"64","author":"Israel","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2021.01.016_b0060","doi-asserted-by":"crossref","unstructured":"D. Porat, M. Markovic, M. Zur, N. Fine-Shamir, C. Azran, G. Shaked, D. Czeiger, J. Vaynshtein, I. Replyanski, G. Sebbag, A. Dahan, Increased paracetamol bioavailability after sleeve gastrectomy: A crossover pre- vs. post-operative clinical trial, J. Clin. Med., 8 (2019) 1949.","DOI":"10.3390\/jcm8111949"},{"key":"10.1016\/j.ejpb.2021.01.016_b0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00268-018-4749-9","article-title":"Assessment of the correlation between preoperative and immediate postoperative gastric volume and weight loss after sleeve gastrectomy using computed tomography volumetry","volume":"43","author":"Elbanna","year":"2019","journal-title":"World J. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1381\/096089201321336584","article-title":"The mini-gastric bypass: experience with the first 1,274 cases","volume":"11","author":"Rutledge","year":"2001","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11695-007-9273-1","article-title":"The ABC System: A simplified classification system for small bowel obstruction after laparoscopic Roux-en-Y gastric bypass","volume":"17","author":"Tucker","year":"2007","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.soard.2017.01.001","article-title":"Making sense of gastric\/intestinal bypass surgeries: Forget the name and remember the degree of restriction and malabsorption the surgeries provide","volume":"13","author":"Nimeri","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.ejpb.2021.01.016_b0085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/jcm9051511","article-title":"Medication management after bariatric surgery: Providing optimal patient care","volume":"9","author":"Porat","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejpb.2021.01.016_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2015.05.013","article-title":"In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib","volume":"76","author":"Tsume","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.01.016_b0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2019.04.034","article-title":"Amorphous solid dispersions of weak bases with pH-dependent soluble polymers to overcome limited bioavailability due to gastric pH variability - An in-vitro approach","volume":"564","author":"Monschke","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1208\/s12249-015-0365-2","article-title":"pH-dependent solubility and dissolution behavior of carvedilol\u2013Case example of a weakly basic BCS class II drug","volume":"17","author":"Hamed","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.01.016_b0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.xphs.2018.11.008","article-title":"Predicting the changes in oral absorption of weak base drugs under elevated gastric pH using an In vitro-in silico-in vivo approach: Case examples-Dipyridamole, prasugrel, and nelfinavir","volume":"108","author":"Kambayashi","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.01.016_b0110","first-page":"166","article-title":"The bioavailability of diazepam from uncoated tablets in humans\u2013Part II: Effect of gastric fluid acidity","volume":"20","author":"Ogata","year":"1982","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.01.016_b0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/med.21403","article-title":"Applications of polymers as pharmaceutical excipients in solid oral dosage forms","volume":"37","author":"Debotton","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejpb.2021.01.016_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105019","article-title":"Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability","volume":"138","author":"Maderuelo","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.01.016_b0130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.ejpb.2013.09.009","article-title":"Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: Case example diclofenac","volume":"85","author":"Kambayashi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s11695-018-3593-1","article-title":"Bariatric surgery worldwide: Baseline demographic description and one-year outcomes from the fourth IFSO Global Registry Report 2018","volume":"29","author":"Welbourn","year":"2019","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/03639040600637564","article-title":"In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55 by fluidized-bed system","volume":"32","author":"Silva","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.2042-7158.1989.tb06479.x","article-title":"Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media","volume":"41","author":"Fassihi","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0150","doi-asserted-by":"crossref","unstructured":"K. Sugano, Theoretical framework II: Dissolution, in: Biopharmaceutics modeling and simulations, Wiley, 2012, pp. 33-63.","DOI":"10.1002\/9781118354339.ch3"},{"key":"10.1016\/j.ejpb.2021.01.016_b0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/S0004-28032007000200015","article-title":"An experimental study of the electrical activity of the bypassed stomach in the Roux-en-Y gastric bypass","volume":"44","author":"Ferraz","year":"2007","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0160","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gutjnl-2015-309242","article-title":"Higher plasma motilin levels in obese patients decrease after Roux-en-Y gastric bypass surgery and regulate hunger","volume":"65","author":"Deloose","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2021.01.016_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.soard.2016.08.004","article-title":"The effect of sleeve gastrectomy on GLP-1 secretion and gastric emptying: A prospective study","volume":"13","author":"Sista","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.ejpb.2021.01.016_b0170","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11695-012-0656-6","article-title":"Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP)","volume":"22","author":"Wang","year":"2012","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejpb.2016.02.002","article-title":"Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process","volume":"101","author":"Kataoka","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.soard.2019.01.001","article-title":"Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects","volume":"15","author":"Azran","year":"2019","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.ejpb.2021.01.016_b0185","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","article-title":"Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery","volume":"23","author":"Pirola","year":"2013","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","article-title":"The administration of L-thyroxine as soft gel capsule or liquid solution","volume":"11","author":"Vita","year":"2014","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.01.016_b0195","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/bcp.13054","article-title":"Drug disposition before and after gastric bypass: Fenofibrate and posaconazole","volume":"82","author":"Gesquiere","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.9758\/cpn.2016.14.3.318","article-title":"Lithium toxicity following vertical sleeve gastrectomy: A case report","volume":"14","author":"Alam","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ejpb.2021.01.016_b0205","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11695-018-3597-x","article-title":"Lithium toxicity with severe bradycardia post sleeve gastrectomy: A case report and review of the literature","volume":"29","author":"Dahan","year":"2019","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JCP.0b013e318210b203","article-title":"Lithium toxicity after Roux-en-Y gastric bypass surgery","volume":"31","author":"Tripp","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0215","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(80)90282-2","article-title":"Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man","volume":"2","author":"Hoftiezer","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2021.01.016_b0220","article-title":"Marginal ulceration following Roux-en-Y gastric bypass: Risk factors for ulcer development, recurrence and need for revisional surgery","author":"Di Palma","year":"2020","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.ejpb.2021.01.016_b0225","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000001300","article-title":"Risk factors for marginal ulcer after gastric bypass surgery for obesity: A population-based cohort study","volume":"263","author":"Sverden","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(00)00200-5","article-title":"pH-Independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets","volume":"67","author":"Streubel","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.01.016_b0235","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s11695-008-9586-8","article-title":"Is a pouch compulsory in Roux-en-Y gastric bypass after failed adjustable gastric banding?","volume":"18","author":"Perathoner","year":"2008","journal-title":"Obes. Surg."},{"key":"10.1016\/j.ejpb.2021.01.016_b0240","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/mp400485k","article-title":"Purely in silico BCS classification: Science based quality standards for the world's drugs","volume":"10","author":"Dahan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.01.016_b0245","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2125.2012.04284.x","article-title":"Trends in oral drug bioavailability following bariatric surgery: Examining the variable extent of impact on exposure of different drug classes","volume":"74","author":"Darwich","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.01.016_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105440","article-title":"Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeability","volume":"152","author":"Markovic","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.01.016_b0255","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/pharmaceutics12121175","article-title":"BCS Class IV oral drugs and absorption windows: Regional-dependent intestinal permeability of furosemide","volume":"12","author":"Markovic","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.01.016_b0260","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.xphs.2018.07.017","article-title":"Segmental-dependent intestinal drug permeability: Development and model validation of in silico predictions guided by in vivo permeability values","volume":"108","author":"Wolk","year":"2019","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:42:10Z","timestamp":1760546530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":52,"alternative-id":["S0939641121000308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.01.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}